Geron Corp (NASDAQ:GERN)
CAPS Rating:
A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.
RSS Headlines
Fool UK
Recs
Once the dems start putting forth their agenda, this co may be way ahead on the stem cell research.